• UPDATE: Regulatory Relief Concerning COVID-19 Pandemic

      • To
      • Members, Member Firms and Market Users
      • From
      • Market Regulation Department
      • #
      • SER-8707R
      • Notice Date
      • 15 January 2021
      • Effective Date
      • 15 January 2021

    • (Special Executive Report (“SER”) S-8707R supersedes SER-8707 issued on January 11, 2021.)

      The Exchanges have been apprised that CFTC Market Participants Division and Division of Market Oversight staff no-action relief extending certain temporary no-action relief granted in response to the COVID-19 pandemic is under review currently and is expected to be issued early next week.  Information regarding CFTC staff no-action relief is posted on the CFTC’s website here.

      Click HERE to view the full advisory.  

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2026 CME Group Inc. All rights reserved.